-
Mashup Score: 1Study Supports the Efficacy, Safety of Ravulizumab for Patients with IgA Nephropathy - 5 month(s) ago
The ravulizumab group had a proteinuria reduction of 40.3% while the placebo group had a reduction of 10.9% by week 26, highlighting ravulizumab’s effectiveness in treating patients with IgA Nephropathy.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0A Case Control Study of Mesoamerican Nephropathy in Farmers with Long-Term Exposure to Agrochemical Compounds in El Salvador - 9 month(s) ago
Chronic kidney diseases (CKD) are very prevalent in Central America, particularly in El Salvador. Mesoamerican nephropathy (MN) is a…
Source: European Medical JournalCategories: Latest Headlines, NephrologyTweet-
Presenting a case control study of Mesoamerican nephropathy in farmers with long-term exposure to agrochemical compounds in El Salvador. Learn more with @EMJReviews 👉 https://t.co/6VEvaACW0L #Nephropathy #ChemicalExposure #Mesoamerican
-
-
Mashup Score: 0Investigating Vascular-Related Complications for Adult with Diabetes - 10 month(s) ago
Researchers at SUNY Downstate University Hospital analysed deaths caused by various vascular complications in adults with diabetes. Read more.
Source: European Medical JournalCategories: Latest Headlines, NephrologyTweet-
The mortality rate associated with vascular complications in adults with diabetes has demonstrated an increase from 2001–2020, with the rise mainly due to an increase in deaths from nephropathy. Learn more with @EMJReviews 👉 https://t.co/7q8f2maC6H #Nephropathy #Diabetes
-
-
Mashup Score: 0
Some kidney donors have diabetes, and little of their natural course of diabetic nephropathy (DN) is known. The aim of this study was to analyze the changes in pathologic lesions in the diabetic donor kidney after KT by performing protocol biopsy two weeks and one year after KT. This retrospective study included 103 patients who underwent KT, with kidneys from donors with a history of diabetes…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet-
#Diabetic #nephropathy in the #KidneyTransplant remains #stable at 1 year folllow up, if the donor with type 2 DM was only managed with #OHA, regardless of the recipient’s status or how well FBS control is achieved https://t.co/M6crQR02Jv https://t.co/AoSHnub87A
-
-
Mashup Score: 0
Study results published in Diabetes Care highlight the importance of maintaining HbA1c lower than 7% to avoid proliferative diabetic retinopathy and macroalbuminuria for people with type 1 diabetes.“Our study determines accurately the levels of long-term sugar that can avoid complications,” Hans J. Arnqvist, MD, PhD, professor in the department of endocrinology and the department of
Source: www.healio.comCategories: Endocrinology, Latest HeadlinesTweet-
Maintaining an #HbA1c of less than 7% may be necessary for people with long-duration type 1 #diabetes to avoid diabetic #retinopathy and #nephropathy. @liu_universitet @DiabetesCareADA https://t.co/TDh35JtQEw
-
-
Mashup Score: 18
Some kidney donors have diabetes, and little of their natural course of diabetic nephropathy (DN) is known. The aim of this study was to analyze the changes in pathologic lesions in the diabetic donor kidney after KT by performing protocol biopsy two weeks and one year after KT. This retrospective study included 103 patients who underwent KT, with kidneys from donors with a history of diabetes…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet-
#Diabetic #nephropathy in the #KidneyTransplant remains #stable at 1 year folllow up, if the donor with type 2 DM was only managed with #OHA, regardless of the recipient’s status or how well FBS control is achieved https://t.co/M6crQR02Jv https://t.co/Sx7pgxCj5a
-
-
Mashup Score: 2
Abstract Objectives The STRENGTH (Study Evaluating the Use of RenalGuard to Protect Patients at High Risk of AKI) study assessed whether RenalGuard (PLC Medical Systems) is superior to standard int…
Categories: Cardiologists, Latest HeadlinesTweet-
the use of #RenalGuard did not decrease (compared with adequate hydration) the incidence of contrast-induced #nephropathy in patients treated for complex CV interventions https://t.co/ka8qcvs6PK #JACCIC @JACCJournals @mmamas1973 @MasriAhmadMD @AnkurKalraMD @CMichaelGibson https://t.co/krpwMvRsa0
-
-
Mashup Score: 0Early Signs and Symptoms of IgA Nephropathy - 2 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the patient population for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the patient population for #ImmunoglobulinA (#IgA) #nephropathy. https://t.co/4idV6CAaEz The IGA Nephropathy Foundation of America @IGANFoundation IGA Nephropathy Foundation
-
-
Mashup Score: 0Management of IgA Nephropathy - 2 year(s) ago
Richard Lafayette, MD, FACP, Director of the Stanford Glomerular Disease Center, Editor-in-Chief of ASN Kidney News, and Rheumatologist at Stanford Health Care, describes the current standard of care for immunoglobulin A (IgA) nephropathy.
Source: CheckRareCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Richard Lafayette, MD, FACP, from Stanford Medicine (@StanfordMed), describes the current standard of care for #ImmunoglobulinA (#IgA) #nephropathy. Read more: https://t.co/LUlmCk4eSk @IGANFoundation IGA Nephropathy Foundation The IGA Nephropathy Foundation of America
-
-
Mashup Score: 0Epigenetics of Diabetic Nephropathy: From Biology to Therapeutics - European Medical Journal - 3 year(s) ago
Diabetic nephropathy (DN) is a lethal microvascular complication associated with Type 1 and Type 2 diabetes mellitus, and is the leading…
Source: European Medical JournalCategories: Latest Headlines, NephrologyTweet-
Learn about the control of cell identity in kidney development and therapeutics in this report on epigenetics of diabetic nephropathy. https://t.co/nUGdGXmrZA #kidneydevelopment #diabetic #nephropathy
-
A new study led by Jonathan Barrett, PhD, @uniofleicester, demonstrates the efficacy and safety of ravulizumab for treating patients with IgA Nephropathy. https://t.co/iV43fmepjP #Nephropathy https://t.co/q2tP4sNCKD